AU734370B2 - Methods for actively binding heparin to biological and non- biological bioprosthetic material - Google Patents

Methods for actively binding heparin to biological and non- biological bioprosthetic material Download PDF

Info

Publication number
AU734370B2
AU734370B2 AU64523/98A AU6452398A AU734370B2 AU 734370 B2 AU734370 B2 AU 734370B2 AU 64523/98 A AU64523/98 A AU 64523/98A AU 6452398 A AU6452398 A AU 6452398A AU 734370 B2 AU734370 B2 AU 734370B2
Authority
AU
Australia
Prior art keywords
biological material
solution
polyamine
contacting
carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU64523/98A
Other languages
English (en)
Other versions
AU6452398A (en
Inventor
Catherine Ting Lee
Jun Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of AU6452398A publication Critical patent/AU6452398A/en
Application granted granted Critical
Publication of AU734370B2 publication Critical patent/AU734370B2/en
Assigned to EDWARDS LIFESCIENCES CORPORATION reassignment EDWARDS LIFESCIENCES CORPORATION Alteration of Name(s) of Applicant(s) under S113 Assignors: BAXTER INTERNATIONAL INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU64523/98A 1997-04-16 1998-03-06 Methods for actively binding heparin to biological and non- biological bioprosthetic material Expired AU734370B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843504 1997-04-16
US08/843,504 US5891196A (en) 1997-04-16 1997-04-16 Method for actively binding heparin to crosslinked biological tissues
PCT/US1998/004508 WO1998046288A1 (en) 1997-04-16 1998-03-06 Methods for actively binding heparin to cross-linked biological tissues

Publications (2)

Publication Number Publication Date
AU6452398A AU6452398A (en) 1998-11-11
AU734370B2 true AU734370B2 (en) 2001-06-14

Family

ID=25290197

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64523/98A Expired AU734370B2 (en) 1997-04-16 1998-03-06 Methods for actively binding heparin to biological and non- biological bioprosthetic material

Country Status (6)

Country Link
US (1) US5891196A (OSRAM)
EP (1) EP0975378A1 (OSRAM)
JP (1) JP2001520539A (OSRAM)
AU (1) AU734370B2 (OSRAM)
CA (1) CA2286900C (OSRAM)
WO (1) WO1998046288A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69523074T2 (de) * 1994-07-29 2002-06-06 Edwards Lifesciences Corp., Irvine Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6206917B1 (en) 1997-05-02 2001-03-27 St. Jude Medical, Inc. Differential treatment of prosthetic devices
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
JP4663120B2 (ja) 1998-09-30 2011-03-30 メドトロニック，インコーポレイテッド 移植で使用される組織の無機質化を減少させる方法
WO2000064371A1 (en) * 1999-04-27 2000-11-02 The Children's Hospital Of Philadelphia Stabilization of implantable bioprosthetic devices
US7604663B1 (en) 1999-12-30 2009-10-20 St. Jude Medical, Inc. Medical devices with polymer/inorganic substrate composites
US6471723B1 (en) 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
US6391538B1 (en) * 2000-02-09 2002-05-21 The Children's Hospital Of Philadelphia Stabilization of implantable bioprosthetic tissue
DE10060660A1 (de) 2000-12-06 2002-06-20 Frey Rainer Verfahren zur Konservierung von biologischen Prothesen, konservierte biologische Prothese und Konservierungslösung
US20020177223A1 (en) * 2001-03-12 2002-11-28 Ogle Mathew F. Methods and compositions for crosslinking tissue
US7078163B2 (en) * 2001-03-30 2006-07-18 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
US20030077310A1 (en) 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
US7989157B2 (en) * 2005-01-11 2011-08-02 Medtronic, Inc. Solution for storing bioprosthetic tissue used in a biological prosthesis
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法
CN100482178C (zh) * 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 带生物膜的血管瘤夹
US20070218038A1 (en) 2006-03-17 2007-09-20 Pegasus Biologics, Inc. Stabilized, sterilized collagen scaffolds with active adjuncts attached
CN113499478B (zh) * 2021-07-07 2022-07-12 成都纽脉生物科技有限公司 一种生物组织材料的处理方法
CN114632194B (zh) * 2022-04-11 2023-05-23 东莞市人民医院 具有长效no催化释放的涂层材料及制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US5134192A (en) * 1990-02-15 1992-07-28 Cordis Corporation Process for activating a polymer surface for covalent bonding for subsequent coating with heparin or the like

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673612A (en) * 1970-08-28 1972-07-04 Massachusetts Inst Technology Non-thrombogenic materials and methods for their preparation
DE2148011C3 (de) * 1970-10-05 1978-11-09 Aminkemi Ab Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen
SE400173B (sv) * 1975-03-20 1978-03-20 Aminkemi Ab Forfarande vid stabilisering av en hepariniserad yta innehallande vid blodkontakt utlosbart heparin
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
IT1081627B (it) * 1977-07-27 1985-05-21 Snam Progetti Procedimento per la preparazione di materiali biocompatibili e manufatti cosi' ottenuti
GB1583008A (en) * 1977-10-19 1981-01-21 Unitika Ltd Process for preparing antithrombogenic ploymeric material
DE2748858A1 (de) * 1977-10-31 1979-05-03 Unitika Ltd Verfahren zur herstellung von antithrombogenem polymerem material
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4250041A (en) * 1979-06-25 1981-02-10 Warner-Lambert Company Removal of heparin from blood plasma samples using an insoluble protamine reaction product
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
SE456347B (sv) * 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
FR2523810B1 (fr) * 1982-03-23 1988-11-25 Carpentier Alain Tissu biologique greffable et procede pour sa preparation
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4820302A (en) * 1982-04-22 1989-04-11 Sterling Drug Inc. Bio compatible and blood compatible materials and methods
US4502159A (en) * 1982-08-12 1985-03-05 Shiley Incorporated Tubular prostheses prepared from pericardial tissue
US4402697A (en) * 1982-08-25 1983-09-06 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
EP0126743B1 (en) * 1982-11-12 1989-04-12 BAXTER INTERNATIONAL INC. (a Delaware corporation) Surfactant treatment of implantable biological tissue to inhibit calcification
US4885005A (en) * 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US4613517A (en) * 1983-04-27 1986-09-23 Becton, Dickinson And Company Heparinization of plasma treated surfaces
JPH0611305B2 (ja) * 1985-07-29 1994-02-16 株式会社高研 抗血栓性材料の製造方法
JPS6238172A (ja) * 1985-08-12 1987-02-19 株式会社　高研 抗血栓性医用材料の製造方法
DE3782394T2 (de) * 1986-03-28 1993-05-19 Toray Industries Immobilisiertes, physiologisch aktives material.
US5215886A (en) * 1987-06-22 1993-06-01 Patel P Jivan HDL determination in whole blood
US4976733A (en) * 1988-02-03 1990-12-11 Biomedical Design, Inc. Prevention of prosthesis calcification
US5342693A (en) * 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
US5338770A (en) * 1988-06-08 1994-08-16 Cardiopulmonics, Inc. Gas permeable thrombo-resistant coatings and methods of manufacture
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5270046A (en) * 1988-09-27 1993-12-14 Ube Industries, Ltd. Heparin bound anti-thrombotic material
KR920700048A (ko) * 1989-04-25 1992-02-19 마에다 가쯔노스께 항혈전성 혈액처리 시스템
JP2874029B2 (ja) * 1989-06-21 1999-03-24 テルモ株式会社 医療用材料およびその製造方法ならびにそれを用いた医療用器具
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
GB9009570D0 (en) * 1990-04-27 1990-06-20 Biocompatibles Ltd Antithrombogenic polymers
US5002256A (en) * 1990-05-11 1991-03-26 Bedford Marlin D Lifting and supporting device
IT1243987B (it) * 1990-10-29 1994-06-28 Derivati Organici Lab Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
US5132108A (en) * 1990-11-08 1992-07-21 Cordis Corporation Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents
US5159050A (en) * 1991-05-09 1992-10-27 Becton, Dickinson And Company Polyurethane and medical article therefrom
US5356433A (en) * 1991-08-13 1994-10-18 Cordis Corporation Biocompatible metal surfaces
WO1993014127A1 (en) * 1992-01-21 1993-07-22 University Of Utah Method and composition for heparin binding using polyaminocations covalently immobilised on polymeric surfaces with polyethylene oxide spacers
US5217743A (en) * 1992-02-07 1993-06-08 Paradigm Biotechnologies Partnership Biomaterials of enhanced biocompatibility
US5336518A (en) * 1992-12-11 1994-08-09 Cordis Corporation Treatment of metallic surfaces using radiofrequency plasma deposition and chemical attachment of bioactive agents
US5308641A (en) * 1993-01-19 1994-05-03 Medtronic, Inc. Biocompatibility of solid surfaces
US5229172A (en) * 1993-01-19 1993-07-20 Medtronic, Inc. Modification of polymeric surface by graft polymerization
US5350800A (en) * 1993-01-19 1994-09-27 Medtronic, Inc. Method for improving the biocompatibility of solid surfaces

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US5134192A (en) * 1990-02-15 1992-07-28 Cordis Corporation Process for activating a polymer surface for covalent bonding for subsequent coating with heparin or the like

Also Published As

Publication number Publication date
CA2286900C (en) 2008-11-25
US5891196A (en) 1999-04-06
CA2286900A1 (en) 1998-10-22
EP0975378A1 (en) 2000-02-02
WO1998046288A1 (en) 1998-10-22
AU6452398A (en) 1998-11-11
JP2001520539A (ja) 2001-10-30

Similar Documents

Publication Publication Date Title
US5891196A (en) Method for actively binding heparin to crosslinked biological tissues
US10434218B2 (en) Pre-stressing and capping bioprosthetic tissue
US4755593A (en) Novel biomaterial of cross-linked peritoneal tissue
CA2261811C (en) Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
JP3768528B2 (ja) 石灰化抵抗性生物人工組織の製造法
EP0888142B1 (en) Nonpolymeric epoxy compounds for cross-linking biological tissue and bioprosthetic grafts prepared thereby
US5447536A (en) Method for fixation of biological tissue
JP4555570B2 (ja) 移植後の石灰化を軽減する生物補綴組織の処理
AU713605B2 (en) Calcification-resistant bioprosthetic tissue and methods of making same
US5645587A (en) Prevention of calcification and degeneration of biological tissue grafts for implantation in humans
US5509932A (en) Fixed tissue medical devices comprising albumin-binding dyes
KR20070106696A (ko) 이식가능한 바이오물질 및 그 제조 방법
AU6154399A (en) Crosslinking of bioprosthetic material to mitigate post-implantation calcification
US20020111532A1 (en) Tris(hydroxymethyl)phosphino compounds as tissue crosslinking agents
Park et al. Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly (ethylene oxide)
KR20010038098A (ko) 헤파린 처리된 항석회화성 생체조직 이식물 및 이의 제조 방법
Vasudev et al. Covalently bonded heparin to alter the pericardial calcification
Santin et al. Changes in serum conditioning profiles of glutaraldehyde‐crosslinked collagen sponges after their treatment with calcification inhibitors
WO2011115612A1 (en) Thin collagen tissue for medical device applications
KR0181691B1 (ko) 항석회화 생체 조직 이식물 및 그의 제조 방법
CN118059314A (zh) 组合型人工心脏瓣膜及其制备方法
Zeeman et al. Cross-linking and calcification of collagen-based materials

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: EDWARDS LIFESCIENCES CORPORATION

Free format text: THE FORMER OWNER WAS: BAXTER INTERNATIONAL INC.

FGA Letters patent sealed or granted (standard patent)